{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:07:05Z","timestamp":1788854825258,"version":"build-2803163510"},"reference-count":219,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,27]],"date-time":"2027-07-27T00:00:00Z","timestamp":1816646400000},"content-version":"am","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37AI128901"],"award-info":[{"award-number":["R37AI128901"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.autrev.2026.104146","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:09:02Z","timestamp":1785103742000},"page":"104146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Germinal center and extrafollicular dysregulation in systemic lupus erythematosus: Mechanisms and therapeutic opportunities"],"prefix":"10.1016","volume":"25","author":[{"given":"Milind V.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmi","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104146_bb0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","article-title":"Anti-DNA antibodies -quintessential biomarkers of SLE","volume":"12","author":"Pisetsky","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0015","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.immuni.2017.06.005","article-title":"Germinal center selection and affinity maturation require dynamic regulation of mTORC1 kinase","volume":"46","author":"Ersching","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0020","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1038\/s41467-018-06686-0","article-title":"Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells","volume":"9","author":"Choi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104146_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2019.07.001","article-title":"Metabolic regulation of pathogenic autoimmunity: therapeutic targeting","volume":"61","author":"Teng","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fimmu.2015.00425","article-title":"Defects in germinal center selection in SLE","volume":"6","author":"Woods","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/08916934.2017.1280671","article-title":"Spontaneous germinal centers and autoimmunity","volume":"50","author":"Domeier","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0040","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104146_bb0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#","article-title":"Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"42","author":"Kanda","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0050","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1172\/JCI78082","article-title":"Sexual dimorphism in autoimmunity","volume":"125","author":"Rubtsova","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104146_bb0055","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/0961203313502571","article-title":"Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes","volume":"22","author":"Gonz\u00e1lez","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2026.104146_bb0060","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.autrev.2026.104146_bb0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2010.176","article-title":"Genetic susceptibility to systemic lupus erythematosus in the genomic era","volume":"6","author":"Deng","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0070","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/jir.2011.0071","article-title":"Interferon alpha as a primary pathogenic factor in human lupus","volume":"31","author":"Niewold","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.autrev.2026.104146_bb0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.12821","article-title":"Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies","volume":"292","author":"Meffre","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2026.104146_bb0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","article-title":"What is damaging the kidney in lupus nephritis?","volume":"12","author":"Davidson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.immuni.2007.12.004","article-title":"Sites and stages of autoreactive B cell activation and regulation","volume":"28","author":"Shlomchik","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2007.01.009","article-title":"Autoreactivity in human IgG+ memory B cells","volume":"26","author":"Tiller","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0100","doi-asserted-by":"crossref","unstructured":"Hampe, C.S. B cell in autoimmune diseases Scientifica (Cairo) 2012, 215308 (2012).","DOI":"10.6064\/2012\/215308"},{"key":"10.1016\/j.autrev.2026.104146_bb0105","doi-asserted-by":"crossref","unstructured":"Jenks, S.A. et al. Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739 e726 (2018).","DOI":"10.1016\/j.immuni.2018.08.015"},{"key":"10.1016\/j.autrev.2026.104146_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/imr.12741","article-title":"Extrafollicular responses in humans and SLE","volume":"288","author":"Jenks","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2026.104146_bb0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41584-026-01365-7","article-title":"Germinal-centre and extrafollicular B cell pathways in systemic lupus erythematosus","volume":"22","author":"Zhu","year":"2026","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni1100","article-title":"Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5","volume":"5","author":"Allen","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2026.104146_bb0130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature13300","article-title":"Clonal selection in the germinal Centre by regulated proliferation and hypermutation","volume":"509","author":"Gitlin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104146_bb0135","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2010.10.032","article-title":"Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter","volume":"143","author":"Victora","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2026.104146_bb0140","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1126\/science.1257861","article-title":"Dynamic signaling by T follicular helper cells during germinal center B cell selection","volume":"345","author":"Shulman","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104146_bb0145","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-7613(94)80021-9","article-title":"Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors","volume":"1","author":"Linsley","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.immuni.2007.04.008","article-title":"Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns","volume":"26","author":"Hauser","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.immunol.26.021607.090248","article-title":"Mechanism and regulation of class switch recombination","volume":"26","author":"Stavnezer","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ni.1715","article-title":"Cytokine-secreting follicular T cells shape the antibody repertoire","volume":"10","author":"Reinhardt","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0165","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1175870","article-title":"Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation","volume":"325","author":"Johnston","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104146_bb0170","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/ni.3226","article-title":"LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6","volume":"16","author":"Choi","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0175","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0180","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1084\/jem.168.3.853","article-title":"Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures","volume":"168","author":"Lebman","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/1074-7613(94)90095-7","article-title":"The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation","volume":"1","author":"Kawabe","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20141432","article-title":"ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2","volume":"212","author":"Weber","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.immuni.2008.12.015","article-title":"Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS","volume":"30","author":"Linterman","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0200","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.immuni.2012.12.004","article-title":"Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation","volume":"38","author":"Vogel","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.20081886","article-title":"Follicular helper T cells are required for systemic autoimmunity","volume":"206","author":"Linterman","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0210","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.2426","article-title":"Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions","volume":"17","author":"Chung","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0215","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0220","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.12411","article-title":"T follicular regulatory cells","volume":"271","author":"Sage","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2026.104146_bb0225","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1002\/art.38735","article-title":"Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 mice","volume":"66","author":"Ding","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0230","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/eji.201546094","article-title":"Follicular regulatory T cells repress cytokine production by follicular helper T cells and optimize IgG responses in mice","volume":"46","author":"Wu","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal Centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104146_bb0240","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1016\/j.immuni.2025.10.008","article-title":"Highly functional and prolonged germinal center T follicular helper cell responses are associated with enhanced neutralizing antibody development","volume":"58","author":"Marina-Zarate","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0245","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1002\/art.11354","article-title":"B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations","volume":"48","author":"Stohl","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0250","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0255","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13192","article-title":"T cell help in the autoreactive germinal center","volume":"95","author":"Akama-Garren","year":"2022","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114978","article-title":"Aberrant zonal recycling of germinal center B cells impairs appropriate selection in lupus","volume":"43","author":"Sanchez","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2026.104146_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113705","article-title":"NGFR regulates stromal cell activation in germinal centers","volume":"43","author":"Hernandez-Barranco","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2026.104146_bb0275","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4049\/jimmunol.1001983","article-title":"In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis","volume":"186","author":"Chang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0280","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","article-title":"Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways","volume":"20","author":"Der","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0285","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0290","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/328805a0","article-title":"The role of clonal selection and somatic mutation in autoimmunity","volume":"328","author":"Shlomchik","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104146_bb0295","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.4049\/jimmunol.161.9.4634","article-title":"B cell deletion, anergy, and receptor editing in \"knock in\" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain","volume":"161","author":"Pewzner-Jung","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0300","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/intimm\/dxh035","article-title":"Germinal center checkpoints in B cell tolerance in 3H9 transgenic mice","volume":"16","author":"Paul","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0305","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1172\/JCI24179","article-title":"Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus","volume":"115","author":"Cappione","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104146_bb0310","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.171.1.265","article-title":"Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation","volume":"171","author":"Shlomchik","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0315","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.immuni.2012.07.017","article-title":"Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen","volume":"37","author":"Chan","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0320","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104146_bb0325","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0330","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrrheum.2014.33","article-title":"The BAFF\/APRIL system in SLE pathogenesis","volume":"10","author":"Vincent","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0335","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","article-title":"Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches","volume":"20","author":"Thien","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0340","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/ni.1666","article-title":"Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling","volume":"9","author":"Stadanlick","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0345","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2003-08-2694","article-title":"BAFF\/BLyS can potentiate B-cell selection with the B-cell coreceptor complex","volume":"103","author":"Hase","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104146_bb0350","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1182\/blood-2011-12-397919","article-title":"Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice","volume":"119","author":"Kil","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104146_bb0355","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1074-7613(01)00100-5","article-title":"Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire","volume":"14","author":"Takahashi","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0360","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.immuni.2008.07.016","article-title":"Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis","volume":"29","author":"Hao","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0365","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.immuni.2015.04.010","article-title":"FAS inactivation releases unconventional germinal center B cells that escape antigen control and drive IgE and autoantibody production","volume":"42","author":"Butt","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928359","article-title":"Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus","volume":"13","author":"Jin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0375","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.25032","article-title":"Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus","volume":"62","author":"Simpson","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0380","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/art.39020","article-title":"Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity","volume":"67","author":"Choi","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0385","first-page":"172","article-title":"Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells","volume":"31","author":"Nakou","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0390","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrrheum.2012.58","article-title":"Follicular helper T cells in immunity and systemic autoimmunity","volume":"8","author":"Craft","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0395","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","article-title":"Interferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers","volume":"37","author":"Lee","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0400","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.4049\/jimmunol.1300675","article-title":"Type I IFN induces binding of STAT1 to Bcl6: divergent roles of STAT family transcription factors in the T follicular helper cell genetic program","volume":"192","author":"Nakayamada","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0405","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1535370218824547","article-title":"IL-12 and IL-23\/Th17 axis in systemic lupus erythematosus","volume":"244","author":"Larosa","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.autrev.2026.104146_bb0410","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1177\/0961203320952841","article-title":"Interleukin 23 is elevated in the serum of patients with SLE","volume":"29","author":"Vukelic","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2026.104146_bb0415","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.20170901","article-title":"Deficiency in T follicular regulatory cells promotes autoimmunity","volume":"215","author":"Fu","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cei.13643","article-title":"Impaired function of PD-1(+) follicular regulatory T cells in systemic lupus erythematosus","volume":"206","author":"Kurata","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0425","doi-asserted-by":"crossref","first-page":"E3216","DOI":"10.1073\/pnas.1312348110","article-title":"T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance","volume":"110","author":"Rubtsova","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104146_bb0430","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-associated B cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0435","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ni.3175","article-title":"Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus","volume":"16","author":"Tipton","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0440","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221346","article-title":"Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice","volume":"220","author":"Nickerson","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0445","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1126\/science.1073924","article-title":"Evolution of autoantibody responses via somatic hypermutation outside of germinal centers","volume":"297","author":"William","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104146_bb0450","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.0800771","article-title":"B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus","volume":"182","author":"Nacionales","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0455","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130062","article-title":"PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21","volume":"4","author":"Bocharnikov","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2026.104146_bb0460","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41586-024-07627-2","article-title":"Interferon subverts an AHR-JUN axis to promote CXCL13(+) T cells in lupus","volume":"631","author":"Law","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104146_bb0465","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s12276-020-0392-2","article-title":"Immune metabolism regulation of the germinal center response","volume":"52","author":"Choi","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0470","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","article-title":"Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis","volume":"21","author":"Weisel","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0475","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.2400285","article-title":"CPT2-mediated fatty acid oxidation is dispensable for humoral immunity","volume":"213","author":"Li","year":"2024","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664249","article-title":"Over-generalizing about GC (hypoxia): pitfalls of limiting breadth of experimental systems and analyses in framing informatics conclusions","volume":"12","author":"Boothby","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0485","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni.3664","article-title":"Gsk3 is a metabolic checkpoint regulator in B cells","volume":"18","author":"Jellusova","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113739","article-title":"GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity","volume":"43","author":"Bierling","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2026.104146_bb0495","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4049\/jimmunol.2200756","article-title":"Plasma cell differentiation, antibody quality, and initial germinal center B cell population depend on glucose influx rate","volume":"212","author":"Brookens","year":"2024","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0500","article-title":"PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma","volume":"132","author":"D'Avola","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104146_bb0505","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/00007890-200003150-00038","article-title":"Mycophenolic acid-induced GTP depletion also affects ATP and pyrimidine synthesis in mitogen-stimulated primary human T-lymphocytes1","volume":"69","author":"Qiu","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2026.104146_bb0510","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacol"},{"key":"10.1016\/j.autrev.2026.104146_bb0515","article-title":"Mycophenolate Mofetil for systemic lupus erythematosus: our 20-year experience","volume":"15","author":"Trevisonno","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2026.104146_bb0520","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2014.02.005","article-title":"Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells","volume":"40","author":"Ray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0525","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.immuni.2015.08.017","article-title":"The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells","volume":"43","author":"Ray","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0530","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/ni.2985","article-title":"Bcl-6 directly represses the gene program of the glycolysis pathway","volume":"15","author":"Oestreich","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0535","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0540","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metabol"},{"key":"10.1016\/j.autrev.2026.104146_bb0545","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89160","article-title":"Foxp3 drives oxidative phosphorylation and protection from lipotoxicity","volume":"2","author":"Howie","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2026.104146_bb0550","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/art.40223","article-title":"Metabolic control of immune system activation in rheumatic diseases","volume":"69","author":"Perl","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0555","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"13","author":"Morel","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0560","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0565","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4049\/jimmunol.1501537","article-title":"Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus","volume":"196","author":"Yin","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116600","article-title":"Glycolysis inhibition functionally reprograms T follicular helper cells and reverses lupus","volume":"44","author":"Choi","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2026.104146_bb0575","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.189858","article-title":"Metabolic pathways within cTfh subsets and glucose-dependent activation of cTfh17 in SLE and healthy individuals","volume":"10","author":"Kim","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2026.104146_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.623844","article-title":"Amino acid metabolism in lupus","volume":"12","author":"Kono","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106774","article-title":"Transcriptional and metabolic programs promote the expansion of follicular helper T cells in lupus-prone mice","volume":"26","author":"Gong","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.autrev.2026.104146_bb0590","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.41019","article-title":"Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL\/lpr mice and experimental autoimmune encephalomyelitis","volume":"71","author":"Kono","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0595","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.192286","article-title":"Intrinsic T cell glutaminolysis promotes autoimmunity in lupus-prone mice","volume":"10","author":"Choi","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2026.104146_bb0600","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/art.42112","article-title":"Role of glutaminase 2 in promoting CD4+ T cell production of interleukin-2 by supporting antioxidant defense in systemic lupus erythematosus","volume":"74","author":"Hisada","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0605","series-title":"Synthetic auxotrophy reveals metabolic regulation of plasma cell generation, affinity maturation, and cytokine receptor signaling","author":"Cho","year":"2025"},{"key":"10.1016\/j.autrev.2026.104146_bb0610","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/art.42433","article-title":"Amelioration of autoimmunity in a lupus mouse model by modulation of T-bet-promoted energy metabolism in pathogenic age\/autoimmune-associated B cells","volume":"75","author":"Han","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0615","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adu6015","article-title":"The m(6)a demethylase FTO links TLR7 to mitochondrial oxidation driving age-associated B cell formation in systemic lupus erythematosus","volume":"17","author":"Zeng","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0620","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0625","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"Activation of the mechanistic target of rapamycin in sle: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2026.104146_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.972397","article-title":"Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes","volume":"13","author":"Jin","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2026.104146_bb0635","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.4049\/jimmunol.169.2.1092","article-title":"Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus","volume":"169","author":"Gergely","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0640","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0645","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq0178","article-title":"Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus","volume":"8","author":"Voss","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0650","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152345","article-title":"Iron-dependent epigenetic modulation promotes pathogenic T cell differentiation in lupus","volume":"132","author":"Gao","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2026.104146_bb0655","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1038\/ncomms7750","article-title":"Mitochondrial function provides instructive signals for activation-induced B-cell fates","volume":"6","author":"Jang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2026.104146_bb0660","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2016.06.011","article-title":"Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells","volume":"45","author":"Lam","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2026.104146_bb0665","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.isci.2018.07.005","article-title":"Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling","volume":"5","author":"Waters","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.autrev.2026.104146_bb0670","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature19334","article-title":"Germinal Centre hypoxia and regulation of antibody qualities by a hypoxia response system","volume":"537","author":"Cho","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104146_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104409","article-title":"Regulation of humoral immune response by HIF-1alpha-dependent metabolic reprogramming of the germinal center reaction","volume":"367","author":"Li","year":"2021","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0680","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1002\/art.20592","article-title":"Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus","volume":"50","author":"Anolik","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0685","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1002\/art.22211","article-title":"B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles","volume":"54","author":"Cambridge","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0690","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","article-title":"Rituximab: mechanism of action","volume":"47","author":"Weiner","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1016\/j.autrev.2026.104146_bb0695","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0700","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0705","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa2410965","article-title":"Efficacy and safety of obinutuzumab in active lupus nephritis","volume":"392","author":"Furie","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0710","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2516150","article-title":"Efficacy and safety of obinutuzumab in active systemic lupus erythematosus","author":"Furie","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0715","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood-2017-03-771832","article-title":"Obinutuzumab: what is there to learn from clinical trials?","volume":"130","author":"Cartron","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104146_bb0720","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1182\/blood-2019-123433","article-title":"Final analysis of GOYA: a randomized, open-label, phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-cell lymphoma","volume":"134","author":"Sehn","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104146_bb0725","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104146_bb0730","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0735","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0740","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up","volume":"390","author":"Muller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0745","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1038\/s41591-025-03937-8","article-title":"Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial","volume":"31","author":"Feng","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0750","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1084\/jem.20040168","article-title":"Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB\/W mice","volume":"199","author":"Hoyer","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0755","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive plasma cells drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0760","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/ard-2023-224152","article-title":"Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus","volume":"82","author":"Alexander","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104146_bb0765","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41591-023-02479-1","article-title":"Daratumumab monotherapy for refractory lupus nephritis","volume":"29","author":"Roccatello","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0770","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/annrheumdis-2014-206016","article-title":"The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus","volume":"74","author":"Alexander","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104146_bb0775","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand","volume":"6","author":"Kawai","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0780","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/annrheumdis-2017-211388","article-title":"Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles","volume":"76","author":"Chamberlain","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104146_bb0785","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0140-6736(26)00691-4","article-title":"Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"407","author":"Clowse","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104146_bb0790","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar6584","article-title":"A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity","volume":"11","author":"Karnell","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0795","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4049\/jimmunol.182.3.1421","article-title":"B7RP-1 blockade ameliorates autoimmunity through regulation of follicular helper T cells","volume":"182","author":"Hu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0800","series-title":"Double-blind, randomized, single ascending dose sudy of the safety and tolerability of MEDI-570 in SLE","author":"A Phase 1","year":"2010"},{"key":"10.1016\/j.autrev.2026.104146_bb0805","first-page":"172","article-title":"Interleukin-21 is increased in active systemic lupus erythematosus patients","volume":"31","author":"Nakou","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb0810","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.4049\/jimmunol.178.6.3822","article-title":"IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression","volume":"178","author":"Herber","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0815","unstructured":"NNC0114\u20130000-0005 First human dose trial in healthy subjects and subjects with rheumatoid arthritis. 2010."},{"key":"10.1016\/j.autrev.2026.104146_bb0820","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/cts.12715","article-title":"A double-blind, phase I, single ascending dose study to assess the safety, pharmacokinetics, and pharmacodynamics of BOS161721 in healthy subjects","volume":"13","author":"Hussaini","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.autrev.2026.104146_bb0825","series-title":"A randomized double-bind phase 1b\/2 combined staggered multiple dose escalation study of BOS161721 in systemic lupus erythematosus (SLE) patients on a background of limited standard of care","author":"NCT03371251","year":"2017"},{"key":"10.1016\/j.autrev.2026.104146_bb0830","doi-asserted-by":"crossref","DOI":"10.4110\/in.2024.24.e2","article-title":"IL-17 and IL-21: their immunobiology and therapeutic potentials","volume":"24","author":"Koh","year":"2024","journal-title":"Immune Netw"},{"key":"10.1016\/j.autrev.2026.104146_bb0835","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/annrheumdis-2016-209595","article-title":"Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab","volume":"76","author":"Cappelli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104146_bb0840","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1136\/annrheumdis-2018-213677","article-title":"Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1","volume":"78","author":"Michot","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104146_bb0845","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/art.1780370219","article-title":"Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus","volume":"37","author":"Warner","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0850","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/0961203307081401","article-title":"Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment","volume":"16","author":"Ramos-Barron","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2026.104146_bb0855","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfn216","article-title":"Rapamycin attenuates the severity of established nephritis in lupus-prone NZB\/W F1 mice","volume":"23","author":"Lui","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2026.104146_bb0860","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0961203307088289","article-title":"Rapamycin prevents the development of nephritis in lupus-prone NZB\/W F1 mice","volume":"17","author":"Lui","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2026.104146_bb0865","first-page":"173","article-title":"mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?","volume":"9","author":"Fernandez","year":"2010","journal-title":"Discov Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0870","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","article-title":"Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus","volume":"192","author":"Kato","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0875","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.22085","article-title":"Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus","volume":"54","author":"Fernandez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0880","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104146_bb0885","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104146_bb0890","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.autrev.2026.104146_bb0895","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104146_bb0900","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 clinical practice guideline for the management of lupus nephritis","volume":"105","author":"Kidney Disease: Improving global outcomes lupus nephritis work, G","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2026.104146_bb0905","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4062\/biomolther.2016.075","article-title":"Enforced expression of CXCR5 drives T follicular regulatory-like features in Foxp3(+) T cells","volume":"25","author":"Kim","year":"2017","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.autrev.2026.104146_bb0910","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.stem.2026.02.006","article-title":"In vivo CAR-Tfh cell reprogramming restores tolerance in a mouse model of autoimmune hepatitis","volume":"33","author":"Zheng","year":"2026","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.autrev.2026.104146_bb0915","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.4049\/jimmunol.178.11.7422","article-title":"Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL\/lpr mice","volume":"178","author":"Jiang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0920","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/blood-2009-03-211763","article-title":"AID constrains germinal center size by rendering B cells susceptible to apoptosis","volume":"114","author":"Zaheen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104146_bb0925","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/acsptsci.1c00064","article-title":"Small molecule inhibitors of activation-induced deaminase decrease class switch recombination in B cells","volume":"4","author":"Alvarez-Gonzalez","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.autrev.2026.104146_bb0930","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/eji.202149324","article-title":"Targeting Bcl6 in the TREX1 D18N murine model ameliorates autoimmunity by modulating T-follicular helper cells and germinal center B cells","volume":"52","author":"Venkatadri","year":"2022","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100928","article-title":"GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice","volume":"297","author":"Pearce","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2026.104146_bb0940","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","article-title":"Pharmacological activation of pyruvate kinase M2 inhibits CD4(+) T cell pathogenicity and suppresses autoimmunity","volume":"31","author":"Angiari","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2026.104146_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103198","article-title":"Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice","volume":"145","author":"Lin","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104146_bb0950","doi-asserted-by":"crossref","DOI":"10.1093\/jimmun\/vkag092","article-title":"GLUT1-mediated glucose flux constrains autoreactive but not foreign antigen-specific B-cell responses","volume":"215","author":"Zhu","year":"2026","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0955","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4049\/jimmunol.2200325","article-title":"Glucose requirement of antigen-specific autoreactive B cells and CD4+ T cells","volume":"210","author":"Abboud","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109133","article-title":"Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR\/P70S6K\/4EBP1 and NLRP3\/caspase-1\/IL-1beta pathways in MRL\/lpr mice","volume":"112","author":"Zhang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2026.104146_bb0965","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00262746","article-title":"Pharmacokinetic and phase I study of intravenous DON (6-diazo-5-oxo-L-norleucine) in children","volume":"21","author":"Sullivan","year":"1988","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.autrev.2026.104146_bb0970","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00216936","article-title":"Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-a in advanced sarcomas and mesotheliomas","volume":"8","author":"Earhart","year":"1990","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.autrev.2026.104146_bb0975","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1535-7163.MCT-19-0319","article-title":"The novel glutamine antagonist prodrug JHU395 has antitumor activity in malignant peripheral nerve sheath tumor","volume":"19","author":"Lemberg","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.autrev.2026.104146_bb0980","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq5925","article-title":"Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug","volume":"8","author":"Rais","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.autrev.2026.104146_bb0985","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104146_bb0990","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13063-023-07083-9","article-title":"Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: a randomized double-blind clinical trial study","volume":"24","author":"Abbasifard","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.autrev.2026.104146_bb0995","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000387","article-title":"Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice","volume":"7","author":"Fortner","year":"2020","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2026.104146_bb1000","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/art.41128","article-title":"Improved mitochondrial metabolism and reduced inflammation following attenuation of murine lupus with coenzyme Q10 analog idebenone","volume":"72","author":"Blanco","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb1005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-019-0032-5","article-title":"Targeting metabolism to regulate immune responses in autoimmunity and cancer","volume":"18","author":"Patel","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2026.104146_bb1010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104146_bb1015","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.3390\/ijms221910514","article-title":"The germinal center milieu in rheumatoid arthritis: the immunological drummer or dancer","volume":"22","author":"Anang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2026.104146_bb1020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104146_bb1025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2013.11.003","article-title":"Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjogren's syndrome","volume":"51","author":"Gong","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104146_bb1030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sjogren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb1035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1016\/j.autrev.2026.104146_bb1040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.22230","article-title":"A gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"Magliozzi","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2026.104146_bb1045","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/b4e623eb-4950-48d9-8d85-8d70426d95a3","article-title":"Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression","volume":"8","author":"Romme Christensen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2026.104146_bb1050","article-title":"T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosis","volume":"6","author":"Jelcic","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.autrev.2026.104146_bb1055","first-page":"68","article-title":"Central role of T follicular helper cells in myasthenia gravis","volume":"58","author":"Wu","year":"2021","journal-title":"Noro Psikiyatr Ars"},{"key":"10.1016\/j.autrev.2026.104146_bb1060","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-07361-x","article-title":"Spatial multi-omics profiling uncovers metabolic heterogeneity in Sjogren's syndrome and identifies PS(36:1) as a potential therapeutic target","volume":"23","author":"Shao","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2026.104146_bb1065","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451381","article-title":"Metabolic reprogramming in stromal and immune cells in rheumatoid arthritis and osteoarthritis: therapeutic possibilities","volume":"55","author":"Henry","year":"2025","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2026.104146_bb1070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3899\/jrheum.110610","article-title":"Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology biologics register","volume":"39","author":"Soliman","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb1075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00415-020-10362-z","article-title":"Rituximab for the treatment of multiple sclerosis: a review","volume":"269","author":"Chisari","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2026.104146_bb1080","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb3900","article-title":"A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus","volume":"6","author":"Ganugula","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.autrev.2026.104146_bb1085","doi-asserted-by":"crossref","unstructured":"Ren, B. et al. Nanoparticle-delivered siRNA targeting NSUN4 relieves systemic lupus erythematosus through declining mitophagy-mediated CD8+T cell exhaustion. MedComm (2020) 6, e70311 (2025).","DOI":"10.1002\/mco2.70311"},{"key":"10.1016\/j.autrev.2026.104146_bb1090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104146_bb1095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2018.07.003","article-title":"Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via toll-like receptor 9 inhibition","volume":"195","author":"Torigoe","year":"2018","journal-title":"Clin Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:14:28Z","timestamp":1788851668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226001606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":219,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1568997226001606"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104146","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germinal center and extrafollicular dysregulation in systemic lupus erythematosus: Mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104146"}}